Australia markets closed


NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
27.65-0.15 (-0.54%)
At close: 04:00PM EDT
28.05 +0.40 (+1.45%)
After hours: 04:41PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.51B
Enterprise value 2.94B
Trailing P/E 8.74
Forward P/E 10.27
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.43
Price/book (mrq)1.65
Enterprise value/revenue 8.74
Enterprise value/EBITDA 9.82

Trading information

Stock price history

Beta (5Y monthly) 0.35
52-week change 380.52%
S&P500 52-week change 3-3.48%
52-week high 332.77
52-week low 312.50
50-day moving average 327.76
200-day moving average 321.94

Share statistics

Avg vol (3-month) 3566.89k
Avg vol (10-day) 3440.19k
Shares outstanding 553.13M
Implied shares outstanding 6N/A
Float 828.26M
% held by insiders 147.26%
% held by institutions 121.97%
Shares short (12 May 2022) 4847.98k
Short ratio (12 May 2022) 41.34
Short % of float (12 May 2022) 43.00%
Short % of shares outstanding (12 May 2022) 41.60%
Shares short (prior month 13 Apr 2022) 4755.33k

Dividends & splits

Forward annual dividend rate 43
Forward annual dividend yield 410.79%
Trailing annual dividend rate 32.65
Trailing annual dividend yield 39.53%
5-year average dividend yield 4N/A
Payout ratio 471.65%
Dividend date 306 June 2022
Ex-dividend date 423 May 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 50.70%
Operating margin (ttm)56.95%

Management effectiveness

Return on assets (ttm)4.81%
Return on equity (ttm)19.33%

Income statement

Revenue (ttm)336.76M
Revenue per share (ttm)6.33
Quarterly revenue growth (yoy)-8.20%
Gross profit (ttm)278.88M
Net income avi to common (ttm)170.74M
Diluted EPS (ttm)3.21
Quarterly earnings growth (yoy)18.10%

Balance sheet

Total cash (mrq)174.05M
Total cash per share (mrq)3.28
Total debt (mrq)1.61B
Total debt/equity (mrq)177.30
Current ratio (mrq)1.57
Book value per share (mrq)17.04

Cash flow statement

Operating cash flow (ttm)213.39M
Levered free cash flow (ttm)65.5M